Discover Antibody Candidates Against a Panel of Hard-to-Drug GPCR Targets: A Synthetic Antibody Library Case Study

Aaron K. Sato, Ph.D., CSO, Biopharma, A division of Twist Bioscience explains how to simplify discovery of anti-GPCR antibodies from a range of synthetic antibody phage display libraries. This presentation will also include a case study highlighting multiple Twist Biopharma libraries that are used in the discovery of antibodies against GLP1R, CRTH2, and CXCR5.